Patient-Derived Cytomegaloviruses with Different Ganciclovir Sensitivities from UL97 Mutation Retain Their Replication Efficiency and Some Kinase Activity In Vitro

Antimicrob Agents Chemother. 2019 Aug 23;63(9):e02425-18. doi: 10.1128/AAC.02425-18. Print 2019 Sep.

Abstract

Mutations in the cytomegalovirus UL97 kinase gene contribute to antiviral resistance. Mutations A594S and G598D from two clinical isolates were analyzed, and bacterial artificial chromosome (BAC)-engineered A594S recombinant cytomegalovirus exhibited a ganciclovir-resistant phenotype on plaque reduction. Viral replication was comparable to that of the wild type. Cell-based kinase activity and autophosphorylation of ectopically expressed proteins showed that mutants retained some kinase activity. This study showed that patient-derived cytomegalovirus with different ganciclovir sensitivities retained replication efficiency and exhibited some kinase activity in vitro.

Keywords: UL97; cytomegalovirus; drug resistance; ganciclovir; mutation; phosphorylation; protein kinase.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents / pharmacology*
  • Cell Line
  • Cell Line, Tumor
  • Cytomegalovirus / drug effects*
  • Cytomegalovirus / enzymology*
  • Cytomegalovirus / genetics
  • Drug Resistance, Viral / genetics
  • Ganciclovir / pharmacology*
  • Humans
  • Mutation / genetics
  • Open Reading Frames / genetics
  • Phosphorylation
  • Protein Kinases / genetics
  • Protein Kinases / metabolism*
  • Virus Replication / drug effects
  • Virus Replication / genetics

Substances

  • Antiviral Agents
  • Protein Kinases
  • Ganciclovir